Characterization of uncertainty in the classification of multivariate assays: application to PAM50 centroid-based genomic predictors for breast cancer treatment plans

por Ebbert, Mark TW, Bastien, Roy RL, Boucher, Kenneth M, Martín, Miguel, Carrasco, Eva, Caballero, Rosalía, Stijleman, Inge J, Bernard, Philip S, Facelli, Julio C
Publicado 2011

Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression

por Kwan, Marilyn L, Kroenke, Candyce H, Sweeney, Carol, Bernard, Philip S, Weltzien, Erin K, Castillo, Adrienne, Factor, Rachel E, Maxfield, Kaylynn S, Stijleman, Inge J, Kushi, Lawrence H, Quesenberry, Charles P, Habel, Laurel A, Caan, Bette J
Publicado 2015

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

por Martín, Miguel, Prat, Aleix, Rodríguez-Lescure, Álvaro, Caballero, Rosalía, Ebbert, Mark T. W., Munárriz, Blanca, Ruiz-Borrego, Manuel, Bastien, Roy R. L., Crespo, Carmen, Davis, Carole, Rodríguez, César A., López-Vega, José M., Furió, Vicente, García, Ana M., Casas, Maribel, Ellis, Matthew J., Berry, Donald A., Pitcher, Brandelyn N., Harris, Lyndsay, Ruiz, Amparo, Winer, Eric, Hudis, Clifford, Stijleman, Inge J., Tuck, David P., Carrasco, Eva, Perou, Charles M., Bernard, Philip S.
Publicado 2013

PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers

por Bastien, Roy RL, Rodríguez-Lescure, Álvaro, Ebbert, Mark TW, Prat, Aleix, Munárriz, Blanca, Rowe, Leslie, Miller, Patricia, Ruiz-Borrego, Manuel, Anderson, Daniel, Lyons, Bradley, Álvarez, Isabel, Dowell, Tracy, Wall, David, Seguí, Miguel Ángel, Barley, Lee, Boucher, Kenneth M, Alba, Emilio, Pappas, Lisa, Davis, Carole A, Aranda, Ignacio, Fauron, Christiane, Stijleman, Inge J, Palacios, José, Antón, Antonio, Carrasco, Eva, Caballero, Rosalía, Ellis, Matthew J, Nielsen, Torsten O, Perou, Charles M, Astill, Mark, Bernard, Philip S, Martín, Miguel
Publicado 2012